Outcomes of Ertl Osteomyoplasty Transtibial Amputation With Primary Targeted Muscle Reinnervation and Regenerative Peripheral Nerve Interface

Ertl骨肌成形术经胫骨截肢联合原发性靶向肌肉再支配和再生性周围神经接口的疗效

阅读:1

Abstract

BACKGROUND: Traditional transtibial amputation (TTA) often results in inadequate residual limb stability and increased risks of phantom limb pain and residual limb pain. The Ertl osteomyoplastic TTA technique with primary targeted muscle reinnervation and regenerative peripheral nerve interface may offer solutions to improve structural stability and reduce peripheral nerve pain. We hypothesize that this advanced TTA technique may reduce phantom limb pain and residual limb pain, while improving residual limb stability, contributing to a higher quality of life compared with traditional methods. METHODS: A retrospective review was conducted of 31 patients with 33 total limbs who underwent Ertl osteomyoplastic TTA with primary targeted muscle reinnervation and regenerative peripheral nerve interface during a 6-year period. Patient-reported quality of life outcomes were assessed using the EuroQol 5-dimension 5-level instrument and EuroQol visual analog scale. RESULTS: At a mean follow-up time of 49.3 months, results suggested high quality of life outcomes with an average EuroQol 5-dimension 5-level instrument index score of 0.879 ± 0.231 and a visual analog scale score of 89.36 ± 11.26. Patients reported low levels of pain, minimal psychological distress, and mild limitations in mobility, usual activities, and self-care, indicating favorable physical and emotional outcomes. CONCLUSIONS: This case series highlighted the value of this more technically complex procedure, which, despite increased operative time and learning curve, is associated with reduced postoperative pain, enhanced limb stability, and improved psychosocial outcomes. These findings support continued adoption and underscore the need for future comparative studies to establish superiority over traditional techniques.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。